Skip to main content

Eric Rhodes

ERS Genomics has appointed Eric Rhodes as CEO. He succeeds founder Shaun Foy who has been appointed chairman of the company's board of directors. Rhodes joins ERS from Horizon Discovery where he was responsible for commercializing Horizon's genome editing technologies and overseeing research and development. Before his time at Horizon, he held various positions focused on gene editing technologies, including director of business development at Sigma-Aldrich and vice president of business development and alliance management at Sangamo Biosciences. 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.